
BioForce Nanosciences Holdings, Inc.
OTC:BFNH
2.29 (USD) • At close November 17, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 0 | 0 | 0 | 0 | 0 | 0.018 | 0.016 | 0.005 | 0.008 | 0.006 | 0 | 0.027 | 0 | 1.125 | 0.415 | 0.14 | 0.138 | 0.809 | 0.699 |
Cost of Revenue
| 0 | 0 | 0 | 0 | 0 | 0.013 | 0.012 | 0.003 | 0.006 | 0.005 | 0 | 0 | 0 | 0.601 | 0.199 | 0.117 | 0.099 | 1.321 | 0.105 |
Gross Profit
| 0 | 0 | 0 | 0 | 0 | 0.004 | 0.005 | 0.001 | 0.002 | 0.001 | 0 | 0.027 | 0 | 0.524 | 0.216 | 0.023 | 0.038 | -0.512 | 0.594 |
Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0.245 | 0.286 | 0.279 | 0.273 | 0.131 | 0 | 1 | 0 | 0.466 | 0.52 | 0.165 | 0.279 | -0.633 | 0.85 |
Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.146 | 0.839 | 0 | 1.019 | 0 | 0 |
General & Administrative Expenses
| 0.067 | 0.472 | 0.486 | 0.502 | 158.409 | 0.051 | 0.071 | 0.033 | 0.008 | 0.003 | 0.003 | 0.005 | 0.004 | 2.494 | 2.523 | 0 | 0 | 0 | 0 |
Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.679 | 0 | 0 | 0 | 0 | 0 |
SG&A
| 0.067 | 0.472 | 0.486 | 0.502 | 158.409 | 0.051 | 0.071 | 0.033 | 0.008 | 0.003 | 0.003 | 0.005 | 0.004 | 3.173 | 2.523 | 0.017 | 0.798 | 0.248 | 1.15 |
Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.023 | 0.568 | -0.524 | -0.279 |
Operating Expenses
| 0.067 | 0.472 | 0.486 | 0.502 | 158.409 | 0.051 | 0.071 | 0.033 | 0.008 | 0.006 | 0.003 | 0.005 | 0.004 | 4.321 | 3.362 | 0.04 | 1.249 | 0.772 | 1.429 |
Operating Income
| 0 | -0.472 | -0.486 | -0.502 | -158.409 | -0.047 | -0.067 | -0.031 | -0.006 | -0.003 | -0.003 | 0.022 | -0.004 | -3.797 | -3.146 | -0.017 | -1.211 | -1.284 | -0.835 |
Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | -2.618 | -4.092 | -6.947 | -0.692 | -0.412 | 0 | 0.83 | 0 | -3.375 | -7.58 | -0.121 | -8.8 | -1.587 | -1.194 |
Total Other Income Expenses Net
| 0 | 0 | 0 | 0 | 0 | 0 | -0.001 | 0 | 0 | 0 | 0 | 0 | 0 | -0.057 | -0.828 | -2.076 | 0.025 | 0 | 0 |
Income Before Tax
| -0.49 | -0.472 | -0.486 | -0.502 | -158.409 | -0.047 | -0.068 | -0.031 | -0.006 | -0.003 | -0.003 | 0.022 | -0.004 | -3.854 | -3.974 | -2.092 | -1.186 | -1.284 | -0.835 |
Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | -2.618 | -4.153 | -6.947 | -0.692 | -0.412 | 0 | 0.83 | 0 | -3.426 | -9.574 | -14.971 | -8.622 | -1.587 | -1.194 |
Income Tax Expense
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net Income
| -0.49 | -0.472 | -0.486 | -0.502 | -158.409 | -0.047 | -0.068 | -0.031 | -0.006 | -0.003 | -0.003 | 0.022 | -0.004 | -3.854 | -3.974 | -2.092 | -1.186 | -1.284 | -0.835 |
Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | -2.618 | -4.153 | -6.947 | -0.692 | -0.412 | 0 | 0.83 | 0 | -3.426 | -9.574 | -14.971 | -8.622 | -1.587 | -1.194 |
EPS
| -0.017 | -0.016 | -0.017 | -0.017 | -9.72 | -0.003 | -0.004 | -0.002 | -0 | -0 | -0 | 0.001 | -0 | -0.14 | -0.14 | -0.12 | -0.55 | -0.67 | -0.44 |
EPS Diluted
| -0.017 | -0.016 | -0.017 | -0.017 | -9.72 | -0.003 | -0.001 | -0.002 | -0 | -0 | -0 | 0.003 | -0 | -0.8 | -0.87 | -0.94 | -0.55 | -0.67 | -0.44 |
EBITDA
| 0 | 0 | -0.486 | -0.502 | -158.409 | -0.047 | -0.067 | -0.031 | -0.006 | 0.003 | -0.003 | 0.022 | -0.004 | -3.54 | -2.944 | -1.683 | -1.075 | -1.19 | -0.758 |
EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | -2.618 | -4.092 | -6.947 | -0.692 | 0.494 | 0 | 0.83 | 0 | -3.146 | -7.092 | -12.041 | -7.812 | -1.471 | -1.085 |